🔎 Trials Near Me

Beranda › Kanker Paru › Florida › Orlando

Uji klinis Kanker Paru di Orlando, FL

21 studi untuk Kanker Paru mencari peserta di lokasi sekitar Orlando (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Menerima pesertaFase 1/2
  • Advent Health, Orlando
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750

A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

Menerima pesertaFase 1/2
  • Clermont Oncology Center ( Site 0041), Clermont · 24 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07286149

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Menerima pesertaFase 2
  • AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · 16 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Menerima pesertaFase 3
  • AdventHealth Cancer Institute, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06765109

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Menerima pesertaFase 3
  • Florida Cancer Specialists, Orlando
  • Orlando Health Ambulatory Care Center, Orlando
  • Orlando Health Cancer Institute, Orlando
  • dan 4 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07222566

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Menerima pesertaFase 2/3
  • Clermont Oncology Center, Clermont · 24 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06712316

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Menerima pesertaFase 1
  • Sarah Cannon Research Institute - Lake Nona Florida, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06293898

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Menerima pesertaFase 3
  • Orlando Health Cancer Institute, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Menerima pesertaFase 1/2
  • Avenzo Therapeutics Recruiting Site, Orlando
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07038343

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

Menerima pesertaFase 3
  • Orlando Health Cancer Center, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07499674

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Menerima pesertaFase 3
  • Orlando Health Cancer Institute, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05624996

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • AdventHealth Celebration, Celebration · 17 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT05592626

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Menerima pesertaFase 1/2
  • Clermont Oncology Center, Clermont · 24 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT04198766

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Menerima pesertaFase 1/2
  • Orlando Health Cancer Institute (Melanoma/NSCLC), Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT06060613

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Menerima pesertaFase 1/2
  • Orlando Health Cancer Institute, Orlando
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT05361174

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Menerima pesertaFase 1
  • Research Site, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT06835569

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1
  • AdventHealth Cancer Institute, Celebration · 17 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mar 2026 · NCT05948865

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

Menerima pesertaFase 1
  • Florida Cancer Specialists & Research Institute, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jan 2026 · NCT07181473

Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Adventhealth, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Nov 2025 · NCT07231159

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Menerima pesertaStudi observasional
  • Charter Research, Winter Park · 5 mi jauhnya
  • I.H.S Health, LLC, Kissimmee · 16 mi jauhnya
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2025 · NCT06122077

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Menerima pesertaStudi observasional
  • Orlando VA Healthcare System, Orlando
Usia 29 hingga 85 · Semua jenis kelamin · Diperbarui 13 Nov 2024 · NCT06426628

Uji klinis Kanker Paru di kota lain

Studi lain di Orlando

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.